Vanguard Personalized Indexing Management
ROIV icon

Vanguard Personalized Indexing Management’s Roivant Sciences ROIV Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
52,378
+4,502
+9% +$133K 0.02% 679
2026
Q1 		$1.33M Buy
47,876
+2,920
+6% +$75K 0.01% 791
2025
Q4 		$976K Buy
44,956
+1,342
+3% +$26.5K 0.01% 923
2025
Q3 		$660K Buy
43,614
+2
+0% +$25 0.01% 1115
2025
Q2 		$492K Buy
43,612
+9,548
+28% +$103K 0.01% 1200
2025
Q1 		$344K Buy
34,064
+2,838
+9% +$30.7K 0.01% 1284
2024
Q4 		$369K Sell
31,226
-7,473
-19% -$88.4K 0.01% 1248
2024
Q3 		$447K Buy
38,699
+11,577
+43% +$132K 0.01% 1149
2024
Q2 		$287K Buy
27,122
+6,928
+34% +$75.9K 0.01% 1294
2024
Q1 		$213K Buy
20,194
+1,452
+8% +$15.7K ﹤0.01% 1419
2023
Q4 		$210K Buy
18,742
+3,955
+27% +$38.5K 0.01% 1396
2023
Q3 		$173K Buy
14,787
+2
+0% +$23 0.01% 1326
2023
Q2 		$149K Buy
14,785
+706
+5% +$6.32K ﹤0.01% 1373
2023
Q1 		$104K Buy
+14,079
New +$116K ﹤0.01% 1399

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Personalized Indexing Management's ROIV Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Roivant Sciences (ROIV) stake by 9.4% in Q2 2026, buying an estimated $133K and bringing the position to 52,378 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #679.

Vanguard Personalized Indexing Management first reported a position in ROIV in Q1 2023 and has held it in 14 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Personalized Indexing Management held 52,378 shares of Roivant Sciences worth $1.85M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 4,502 Roivant Sciences shares in Q2 2026, an estimated $133K.
  • Roivant Sciences made up 0.02% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #679 holding.
  • Vanguard Personalized Indexing Management first reported a position in Roivant Sciences in Q1 2023 and has held it in 14 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.